NTRK3 and congenital fibrosarcoma: Specifically, ETV6–NTRK3 fusions (EN; t(12;15) (p13;q25)) have been previously characterized in the setting of secretory breast carcinoma [24, 39], congenital fibrosarcoma [40], thyroid carcinoma [41], and pontine gliomas [23].